Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its
November 14, 2025
Flight crew rescues hiker with head injury from Virginia mountain
Navy veteran owed thousands of dollars from military
FBI director Kash Patel files $250M defamation lawsuit against The Atlantic
Switzerland great Marcel Hug claims his ninth Boston Marathon wheelchair title and fourth straight
Anxiety mounts in London’s Jewish community amid wave of antisemitic attacks
We designed the turf for soccer’s biggest World Cup ever – here’s how we created the same playing experience across 3 countries
Virginia Sen. Mark Warner's daughter has died: 'Heartbroken beyond words'
49ers agree to a 2-year, $50 million contract with star left tackle Trent Williams